Anzeige
Mehr »
Samstag, 28.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0MNB5 | ISIN: SE0000454746 | Ticker-Symbol: PQX1
Tradegate
27.06.25 | 14:27
12,860 Euro
-0,16 % -0,020
1-Jahres-Chart
BIOTAGE AB Chart 1 Jahr
5-Tage-Chart
BIOTAGE AB 5-Tage-Chart
RealtimeGeldBriefZeit
12,77012,98013:03
12,81012,94027.06.

Aktuelle News zur BIOTAGE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiKKR: RWK Bidco AB completes the recommended cash offer to the shareholders of Biotage AB and becomes the owner of 93.12 percent of the shares and extends the acceptance period2
BIOTAGE Aktie jetzt für 0€ handeln
09.06.KKR: RWK Bidco AB has obtained all approvals from authorities deemed necessary for the recommended cash offer to the shareholders of Biotage AB6
12.05.KKR: RWK Bidco AB publishes the offer document for the recommended cash offer to the shareholders of Biotage AB9
25.04.Dividendenbekanntmachungen (25.04.2025)15.050 Unternehmen  ISIN-Code  Dividende (Währung)  Dividende (EUR)  ABG SUNDAL COLLIER HOLDING ASA  NO0003021909  0,5 NOK  0,0422 EUR  ABN AMRO BANK NV  NL0011540547 - 0,75 EUR  ABSA GROUP LIMITED ADR  US00400T1025  0...
► Artikel lesen
24.04.Biotage AB: Resolutions at the Annual General Meeting in Biotage AB (publ) on 24 April 2025200Biotage AB (publ) (Reg. No. 556539-3138) today, on 24 April 2025, held its Annual General Meeting. The Board of Directors' complete proposals have previously been published and are available at the...
► Artikel lesen
23.04.Biotage Q1 2025 slides: Revenue falls 20% amid Astrea transition, shares surge 56%3
22.04.KKR offers $1.2bn to buy Swedish life sciences group Biotage8
22.04.KKR unterbreitet Barangebot von 1,22 Milliarden US-Dollar für schwedisches Biotech-Unternehmen Biotage24
22.04.KKR makes $1.22 billion cash offer for Swedish biotech firm Biotage6
22.04.BIOTAGE AB Q1 Profit Falls3
22.04.KKR makes $1.2 billion offer for Swedish life-sciences company Biotage7
22.04.KKR makes $1.2 billion offer for Sweden's Biotage5
22.04.Biotage AB: Biotage AB (publ) Interim report January-March 2025184Building for the future January - MarchNet sales amounted to SEK 385 (480) million, a decrease of 19.9 percent and an organic* decrease of 20.4 percent.EBITDA amounted to SEK 28 (112) million and the...
► Artikel lesen
22.04.Biotage AB: Statement by the Board of Directors of Biotage in relation to the public offer from RWK BidCo218The Board of Directors of Biotage has concluded to recommend that the shareholders of Biotage accept the public offer from RWK BidCo, based on the assessment outlined below. Background This statement...
► Artikel lesen
22.04.KKR: RWK Bidco AB announces a recommended cash offer of SEK 145 per ordinary share to the shareholders of Biotage AB13
19.02.Biotage AB: Biotage AB (publ) Year end Report January-December 2024343FY revenues exceed 2 BSEK, with growth in margins, adjusted EBITDA and cash generation October - DecemberNet sales amounted to SEK 582 (643) million, a decrease of 9.5 percent and an organic decrease...
► Artikel lesen
23.10.24Biotage AB: Biotage AB (publ) Interim report January-September 2024248Good Q3 execution delivering strong organic growth July - SeptemberNet sales amounted to SEK 490 (449) million, an increase of 9.1 percent and an organic* increase of 12.4 percent.EBITDA amounted to...
► Artikel lesen
13.08.24Biotage AB: Biotage AB appointment of new CEO386BiotageAB (STO:BIOT) ("Biotage"), the leading global separations Company developing intelligent workflow solutions for drug discovery and development through to diagnostics, has today announced the...
► Artikel lesen
16.07.24Biotage AB: Biotage AB (publ) Interim report January-June 2024333Return to Organic Growth with Increased Gross Margin April - JuneNet sales amounted to SEK 504 (409) million, an increase of 23.4 percent and an organic* increase of 9.3 percent.EBITDA amounted to SEK...
► Artikel lesen
19 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1